Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever
Authors:
- G P AcharyaGAG P Acharya
- K E KafleKKK E Kafle
- F NostenFNF Nosten
- D A DanceD A Dance
Open Access
- 1 July 1997
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 40 (1) , 91-98
Abstract
Chloramphenicol pharmacokinetics were studied in 29 Nepalese adults diagnosed with uncomplicated enteric fever and randomized to receive succinate ester 30 mg/kg i.v. or i.m. Serial plasma concentrations of chloramphenicol, and iothalamate (to estimate glomerular filtration rate), antipyrine (hepatocellular function) and Indocyanine Green (liver blood flow) were measured by HPLC and kinetic parameters estimated by non-compartmental analysis. In culture-positive patients (n = 16), mean residence times (MRTs) and steady-state volumes of distribution (V(d)ss) for i.v. chloramphenicol (mean +/- S.D.; 4.9 +/- 0.9 h and 1.9 +/- 0.8 L/kg; n = 7) were less than after i.m. chloramphenicol (12.3 +/- 7.3 h and 3.7 +/- 2.5 L/kg; n = 9; P < 0.05), with a higher peak plasma concentration after i.v. (16.2 +/- 9.1 versus 7.8 +/- 3.6 mg/L; P < 0.05); plasma clearance (Cl(p)) was similar in the two groups (368 +/- 172 and 310 +/- 224 mL/kg/min after i.v. and i.m. respectively). In 17 patients examined during convalescence, MRT and Vdss were less than in acute illness regardless of route chloramphenicol administration. There were similar changes in chloramphenicol kinetic parameters in culture-negative patients. Antipyrine Cl(p) and liver blood flow correlated weakly with chloramphenicol Cl(p) in culture-positive patients (P < 0.1) and were higher in convalescence; no such associations were seen for iothalamate Cl(p). These data indicate that i.v. chloramphenicol produces peak plasma concentrations which are on average twice those after i.m. injection of the same dose, due principally to a smaller V(d)ss. Cl(p) is uninfluenced by route of administration and is determined more by hepatic metabolism than renal excretion. Intramuscular treatment may result in sub-therapeutic chloramphenicol concentrations initially, but continued regular i.v. dosing is more likely to produce levels at which bone marrow toxicity occurs.Keywords
This publication has 16 references indexed in Scilit:
- Does chloramphenicol remain the drug of choice for typhoid?Epidemiology and Infection, 1987
- Absorption of Chloramphenicol Sodium Succinate after Intramuscular Administration in ChildrenNew England Journal of Medicine, 1985
- The pharmacokinetics of chloramphenicol in the neonate and young infantJournal of Antimicrobial Chemotherapy, 1983
- Clearance and Non-Invasive Determination of the Hepatic Extraction of Indocyanine Green in Baboons and ManClinical Science, 1983
- Pharmacokinetic study of chloramphenicol in patients with liver diseaseEuropean Journal of Clinical Pharmacology, 1981
- Chloramphenicol sodium succinate kinetics in critically ill patientsClinical Pharmacology & Therapeutics, 1980
- Micro-scale method for liquid-chromatographic determination of chloramphenicol in serum.Clinical Chemistry, 1979
- Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease—a hypothesisClinical Pharmacology & Therapeutics, 1979
- Efficacy of intramuscular chloramphenicol in treatment of H. influenzae meningitisThe Journal of Pediatrics, 1972
- Evaluation of Chloramphenicol Acid Succinate Therapy of Induced Typhoid Fever and Rocky Mountain Spotted FeverNew England Journal of Medicine, 1970